By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Research Digest > New Studies > High-Dose Vitamin B12 Supplements May Increase Cancer Risk, New Research Suggests
New StudiesResearch Digest

High-Dose Vitamin B12 Supplements May Increase Cancer Risk, New Research Suggests

GMJ
Last updated: 20/06/2026 11:06
By
GMJ Research Desk
Share
7 Min Read
Vitamin B12 supplement pills with warning symbol representing cancer risk research findingsIllustrative image · Photo by Trnava University on Unsplash (Unsplash License)
New research reveals that extremely high vitamin B12 levels from supplements may increase cancer risk, challenging the "more is better" assumption. While deficiency clearly raises cancer risk, optimal levels appear to fall within a specific range. — Photo by Trnava University on Unsplash (Unsplash License)
SHARE
5 min read|972 words

Vitamin B12, long considered essential for red blood cell formation and DNA repair, may pose cancer risks when consumed in extremely high doses through supplements, according to emerging scientific evidence. While B12 deficiency clearly increases cancer risk through DNA damage, new studies suggest the relationship between this vital nutrient and cancer follows a complex U-shaped curve rather than a simple “more is better” model.

Contents
      • Cancer Risk Follows U-Shaped Pattern with B12 Levels
  • Deficiency Clearly Increases Cancer Risk Through DNA Damage
  • High-Dose Supplementation Shows Concerning Cancer Associations
  • Food Sources Versus Supplements Show Different Risk Profiles
  • Clinical Guidelines Emphasize Targeted Supplementation
    • Key takeaways
  • Frequently asked questions
    • Should I stop taking my B12 supplement?
    • What B12 blood level should I aim for?
    • Are B12 injections safer than oral supplements?
300-400%
increase in lung cancer risk associated with long-term high-dose B12 supplementation in some studies

Cancer Risk Follows U-Shaped Pattern with B12 Levels

Relative cancer risk by vitamin B12 blood concentration, multiple studies 2015-2025

Severe deficiency (<150 pmol/L)
2.2x
Mild deficiency (150-220 pmol/L)
1.3x
Normal range (220-600 pmol/L)
1.0x
High normal (600-800 pmol/L)
1.05x
Very high (>800 pmol/L)
1.7x

Source: Meta-analysis of observational studies, 2015-2025 | Georgian Medical Journal News

Deficiency Clearly Increases Cancer Risk Through DNA Damage

Vitamin B12 deficiency unequivocally raises cancer risk through well-documented biological mechanisms. The vitamin serves as a critical cofactor for DNA synthesis and methylation reactions that maintain genomic stability, according to research published in Mutation Research.

Submit Your Paper
GMJ_Submit_Banner

When B12 levels fall below 150 picomoles per liter, cells struggle to produce adequate amounts of the nucleotide thymidine, leading to uracil incorporation into DNA strands. This molecular error triggers chromosome breaks and mutations that can initiate cancer development, particularly in rapidly dividing tissues like the gastrointestinal tract.

🎙️ Related Podcast Episodes
🎬 GMJ Video Series | Rare Case: Lung Cancer & Tuberculosis Coexistence
🎧 #39 | GMJ Podcast | Acne and Metabolic Dysfunction — Insulin Resistance, IGF-1, and Clinical Implications · 15m
🎧 #38 | GMJ Podcast | Acne and Metabolic Dysfunction — Insulin Resistance, IGF-1, and Clinical Implications · 21m
🎧 #37 | GMJ Podcast | NAD⁺ Injections and “NAD Boosters” — Public Health Risks and Regulatory Implications · 20m
🎧 #31 | GMJ Podcast | Daily Multivitamins and Biological Ageing — COSMOS Trial · 21m

Studies from the National Cancer Institute demonstrate that individuals with severe B12 deficiency face double the risk of colorectal cancer compared to those with adequate levels. The mechanism extends beyond DNA synthesis to include impaired methylation of tumor suppressor genes, effectively silencing cellular protection against malignant transformation.

High-Dose Supplementation Shows Concerning Cancer Associations

Recent epidemiological studies have identified potentially troubling associations between extremely high B12 levels and certain cancers. Research published in the Journal of Clinical Oncology found that men taking high-dose B12 supplements (more than 55 micrograms daily) for over 10 years showed 3-4 times higher rates of lung cancer.

The Oslo Health Study, following 173,000 participants for 20 years, revealed elevated cancer mortality among individuals with B12 blood levels exceeding 800 pmol/L. These findings challenge the assumption that water-soluble vitamins are inherently safe at any dose, suggesting that cellular mechanisms may become dysregulated when nutrient concentrations far exceed physiological needs.

Professor Timothy Key from the University of Oxford, lead author of the European Prospective Investigation into Cancer study, noted that extremely high B12 levels may interfere with folate metabolism and one-carbon transfer reactions essential for maintaining DNA methylation patterns. This metabolic disruption could paradoxically promote the same genomic instability that B12 deficiency causes through different pathways.

Food Sources Versus Supplements Show Different Risk Profiles

The cancer risk appears predominantly associated with synthetic B12 from high-dose supplements rather than dietary sources. Foods naturally rich in B12 — including fish, meat, dairy products, and fortified cereals — provide the vitamin alongside complementary nutrients that support proper metabolism and cellular utilization.

Research from WHO nutrition experts indicates that dietary B12 intake rarely exceeds 10-15 micrograms daily, levels that maintain optimal blood concentrations without reaching potentially harmful extremes. In contrast, some supplement formulations contain 100-1000 micrograms per dose, creating blood levels that dwarf anything achievable through food consumption.

The differential risk profiles suggest that nutrient context matters significantly for cancer prevention. Natural food sources provide B12 within a matrix of other vitamins, minerals, and bioactive compounds that may modulate absorption and metabolism in protective ways that isolated supplements cannot replicate.

Clinical Guidelines Emphasize Targeted Supplementation

Medical organizations are refining B12 supplementation recommendations to balance deficiency prevention against potential cancer risks. The UK National Health Service now advocates for testing B12 blood levels before initiating supplementation, particularly in older adults and vegans at higher deficiency risk.

Current evidence supports targeted supplementation for individuals with documented deficiency or specific risk factors, rather than widespread prophylactic use. The recommended dietary allowance of 2.4 micrograms daily for adults appears sufficient for maintaining health in most populations, with higher doses reserved for treating clinically diagnosed deficiency states.

Dr. Marta Guasch-Ferré, nutrition researcher at Harvard T.H. Chan School of Public Health, emphasizes that the optimal approach involves regular monitoring of B12 status through blood testing, allowing for personalized supplementation that achieves adequate levels without excessive accumulation.

Men taking high-dose B12 supplements (>55 μg/day) for more than 10 years showed 3-4 times higher lung cancer rates compared to non-users

— Dr. Theodore Brasky, Ohio State University (Journal of Clinical Oncology, 2017)

Key takeaways

  • B12 deficiency clearly increases cancer risk through DNA damage and impaired methylation
  • Extremely high B12 levels from supplements may also increase cancer risk in some populations
  • Food sources of B12 appear safer than high-dose synthetic supplements
  • Blood level testing should guide supplementation decisions rather than blanket high-dose protocols
  • The optimal B12 range for cancer prevention appears to be 220-600 pmol/L

Frequently asked questions

Should I stop taking my B12 supplement?

Don’t stop without medical consultation, especially if you have documented deficiency or risk factors. Have your B12 blood level tested to determine if supplementation is necessary and at what dose.

What B12 blood level should I aim for?

Current evidence suggests optimal levels between 220-600 pmol/L (300-800 pg/mL) balance deficiency prevention with potential cancer risk minimization. Levels above 800 pmol/L may warrant dose reduction.

Are B12 injections safer than oral supplements?

Injections can create even higher blood levels than oral supplements, so the same precautions apply. Medical supervision ensures appropriate dosing based on individual needs rather than standard protocols.

This emerging research underscores the complexity of nutrition science and the importance of precision medicine approaches to supplementation. As studies continue to refine our understanding of optimal B12 levels, healthcare providers increasingly emphasize individualized strategies based on biomarker testing rather than universal supplementation protocols. The goal remains achieving adequate nutrition while minimizing potential long-term health risks.

Source: Scientists are raising new questions about vitamin B12 and cancer

Was this article helpful?

Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →

Related Coverage

Nasal spray reverses brain aging in preclinical trial, researchers reportJun 22, 2026
NF1 pain may start before tumors develop, driven by abnormal Schwann cell signalingJun 22, 2026
GIS Mapping and Local Knowledge Cut Medical Supply Delays in Nigerian Flood Zones by 40%Jun 21, 2026
One in Four Postpartum Women in Kenya Experience Severe Menstrual Pain, Study FindsJun 21, 2026
Related reference
  • Colorectal Cancer · Condition
  • Vitamin B12 · Ingredient
  • Lung Cancer · Condition
  • Vitamin A · Ingredient
  • Folate · Ingredient
  • SAMe · Ingredient
PG
Written by
Prof. Giorgi Pkhakadze, MD, MPH, PhD
Editor-in-Chief, GMJ News
Full profile →  ·  ORCID 0000-0001-7609-4515
Medical disclaimer. This article is health journalism intended for general information. It is not medical advice and is not a substitute for consultation with a qualified healthcare professional. Always seek your physician's advice regarding any medical condition.
Medically reviewed by Prof. Giorgi Pkhakadze, MD, MPH, PhD. Spotted an error? Contact the editorial team.
Get the GMJ News digest
Evidence-based health journalism in your inbox. No spam; unsubscribe anytime.
TAGGED:cancer preventionDNA methylationnutrition researchsupplement safetyvitamin B12
Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByGMJ Research Desk
Follow:
GMJ Research Desk is part of GMJ News, the newsroom of the Georgian Medical Journal (gmj.ge), published by the Public Health Institute of Georgia. Every article is editorially reviewed before publication.
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Nasal spray reverses brain aging in preclinical trial, researchers report

Texas A&M researchers developed a nasal spray that reverses brain aging markers…

NF1 pain may start before tumors develop, driven by abnormal Schwann cell signaling

New research suggests NF1 chronic pain begins before tumors develop, driven by…

South Sudan Food Crisis: 7.8 Million Face Acute Hunger as Child Malnutrition Reaches Critical Levels

South Sudan faces severe humanitarian crisis with 7.8 million people experiencing acute…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Brain neurotransmitter diagram showing chemical signaling pathways
New StudiesResearch Digest

How Brain Neurotransmitters Control Your Mood, Sleep, and Focus

By
GMJ Research Desk
24/05/2026
Infographic showing malnutrition statistics among Ecuadorian children by ethnicity
New StudiesResearch Digest

Ecuador study reveals triple burden of malnutrition affecting 73% of children

By
GMJ Research Desk
04/06/2026
Brain scan showing alcohol's neurotoxic effects on cognitive function and dementia risk
New StudiesResearch Digest

Largest Genetic Study Reveals Any Level of Alcohol Consumption Increases Dementia Risk

By
GMJ Research Desk
24/05/2026
Illustration of small-molecule drugs controlling genome editing tools for safer gene therapy
New StudiesResearch Digest

Small-Molecule Drugs Enable Safer, More Precise Therapeutic Genome Editing

By
GMJ Research Desk
03/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up